Literature DB >> 8921397

Base substitution at different alternative splice donor sites of the tyrosinase gene in murine albinism.

N Le Fur1, S R Kelsall, B Mintz.   

Abstract

The c2j albino mutation at the mouse tyrosinase locus arose spontaneously in the C57BL/6 inbred strain and causes complete absence of melanin synthesis, as does the "classical" c mutation of long-established albino inbred strains. Sequence analysis of c2j cDNA reveals a G-->T point mutation at nt 291, causing an arginine-->leucine substitution in codon 77, where the arginine position has been conserved in vertebrate tyrosinases and tyrosinase-related proteins. While c2j differs from c, in which there is a G-->C mutation at nt 369 causing a cysteine-->serine substitution, both mutations change the G1 position of alternative 5' splice donor sites in exon 1. Both c2j and c abolish the usage of the respective sites for alternative splicing of the tyrosinase pre-mRNA in skin melanocytes. In c2j, there results an almost eightfold increase in activation of the 5' splice site located 78 nt downstream, but in c there is no activation of the intact upstream splice site. Although the tyrosinase mRNA levels are similar in c2j and wildtype, the protein is virtually absent in c2j, as in c, possibly due to proteolytic degradation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921397     DOI: 10.1006/geno.1996.0551

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  29 in total

1.  Superovulation strategies for 6 commonly used mouse strains.

Authors:  Charlie Luo; Juliana Zuñiga; Earnessa Edison; Shana Palla; Wenli Dong; Jan Parker-Thornburg
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-07       Impact factor: 1.232

2.  The Tyr (albino) locus of the laboratory mouse.

Authors:  Friedrich Beermann; Seth J Orlow; M Lynn Lamoreux
Journal:  Mamm Genome       Date:  2004-10       Impact factor: 2.957

3.  Up-regulation of specific tyrosinase mRNAs in mouse melanomas with the c2j gene substituted for the wild-type tyrosinase allele: utilization in design of syngeneic immunotherapy models.

Authors:  N Le Fur; W K Silvers; S R Kelsall; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

4.  Tyrosinase is the modifier of retinoschisis in mice.

Authors:  Britt A Johnson; Brian S Cole; Eldon E Geisert; Sakae Ikeda; Akihiro Ikeda
Journal:  Genetics       Date:  2010-09-27       Impact factor: 4.562

5.  Genetic variation in C57BL/6 ES cell lines and genetic instability in the Bruce4 C57BL/6 ES cell line.

Authors:  Elizabeth D Hughes; Yun Yan Qu; Suzanne J Genik; Robert H Lyons; Christopher D Pacheco; Andrew P Lieberman; Linda C Samuelson; Igor O Nasonkin; Sally A Camper; Margaret L Van Keuren; Thomas L Saunders
Journal:  Mamm Genome       Date:  2007-09-09       Impact factor: 2.957

6.  Microarray analysis of iris gene expression in mice with mutations influencing pigmentation.

Authors:  Colleen M Trantow; Tryphena L Cuffy; John H Fingert; Markus H Kuehn; Michael G Anderson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

7.  Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.

Authors:  Ighovie F Onojafe; David R Adams; Dimitre R Simeonov; Jun Zhang; Chi-Chao Chan; Isa M Bernardini; Yuri V Sergeev; Monika B Dolinska; Ramakrishna P Alur; Murray H Brilliant; William A Gahl; Brian P Brooks
Journal:  J Clin Invest       Date:  2011-10       Impact factor: 14.808

8.  Cryopreserved morulae can be used to efficiently generate germline-transmitting chimeras by blastocyst injection.

Authors:  Janice V Parker-Thornburg; Jennifer L Alana; Chad N Smith; Michelle Detry; Marta L Rojas; Kedryn K Baskin
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

9.  Elevated oxidative membrane damage associated with genetic modifiers of Lyst-mutant phenotypes.

Authors:  Colleen M Trantow; Adam Hedberg-Buenz; Sachiyo Iwashita; Steven A Moore; Michael G Anderson
Journal:  PLoS Genet       Date:  2010-07-01       Impact factor: 5.917

10.  Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression.

Authors:  B Ferguson; R Ram; H Y Handoko; P Mukhopadhyay; H K Muller; H P Soyer; G Morahan; G J Walker
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.